We are live on ! Find out more
CVKD icon

Cadrenal Therapeutics
CVKD

16 hedge funds and large institutions have $1.22M invested in Cadrenal Therapeutics in 2025 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

468% more capital invested

Capital invested by funds: $215K → $1.22M (+$1.01M)

300% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 2

300% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 1

60% more funds holding

Funds holding: 10 → 16 (+6)

2.85% more ownership

Funds ownership: 0.84% → 3.69% (+2.9%)

Holders
16
Holders Change
+6
Holders Change %
+60%
% of All Funds
0.21%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
4
Reduced
1
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$839K
2
UBS Group
UBS Group
Switzerland
+$115K
3
Geode Capital Management
Geode Capital Management
Massachusetts
+$28.2K
4
Osaic Holdings
Osaic Holdings
Arizona
+$18.4K
5
Jones Financial Companies
Jones Financial Companies
Missouri
+$3.16K

Top Sellers

Rank Fund Capital Flow
1
TRCT
Tower Research Capital (TRC)
New York
-$5.33K
2
RS
R Squared
Hong Kong
-$580
3
Morgan Stanley
Morgan Stanley
New York
-$294
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$805K +$839K +45,633 New
Geode Capital Management
2
Geode Capital Management
Massachusetts
$213K +$28.2K +1,532 +15%
UBS Group
3
UBS Group
Switzerland
$149K +$115K +6,273 +289%
Osaic Holdings
4
Osaic Holdings
Arizona
$26.4K +$18.4K +1,000 +200%
Morgan Stanley
5
Morgan Stanley
New York
$19.9K -$294 -16 -1%
Jones Financial Companies
6
Jones Financial Companies
Missouri
$3.17K +$3.16K +172 New
JP Morgan Chase
7
JP Morgan Chase
New York
$1.76K +$1.84K +100 New
Wells Fargo
8
Wells Fargo
California
$1.76K +$1.84K +100 New
PWA
9
Physician Wealth Advisors
Utah
$917 +$956 +52 New
AIC
10
Archer Investment Corporation
Indiana
$617 – – –
IA
11
IFP Advisors
Florida
$529 +$552 +30 New
FFA
12
Farther Finance Advisors
California
$437 – – –
CWA
13
Carolina Wealth Advisors
South Carolina
$353 – – –
Bank of America
14
Bank of America
North Carolina
$194 +$18 +1 +10%
FFA
15
Frazier Financial Advisors
Ohio
$177 +$184 +10 New
CSC
16
Caldwell Sutter Capital
California
$88 +$92 +5 New
TRCT
17
Tower Research Capital (TRC)
New York
– -$5.33K -368 Closed
RS
18
R Squared
Hong Kong
– -$580 -40 Closed

CVKD Hedge Fund Activity: Q1 2025 in Review

16 of the 7,464 institutional investors tracked by Wall St. Rank reported a position in Cadrenal Therapeutics (CVKD) for Q1 2025, worth a combined $1.22M — up 468% from $215K a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new CVKD positions and 2 closed out — a net gain of 6 holders — while 4 added to existing stakes and 1 trimmed.

The largest buyer was Vanguard Group, opening a new position worth an estimated $839K. The largest seller was Tower Research Capital (TRC), exiting entirely with an estimated $5.33K sold.

  • 16 institutional investors held Cadrenal Therapeutics (CVKD) as of Q1 2025, up from 10 in Q4 2024.
  • Funds reported $1.22M of Cadrenal Therapeutics stock for Q1 2025, up 468% quarter-over-quarter.
  • 8 funds opened new Cadrenal Therapeutics positions in Q1 2025 and 2 closed out, a net change of +6 holders.
  • The largest Cadrenal Therapeutics buyer in Q1 2025 was Vanguard Group, an estimated $839K added.
  • The largest Cadrenal Therapeutics seller in Q1 2025 was Tower Research Capital (TRC), an estimated $5.33K sold.

Based on aggregated 13F filings for Q1 2025.